The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Bristol-Myers Squibb Australia Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
175 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for INREBIC fedratinib (as hydrochloride) 100 mg capsule bottle.
-
Prescription medicine registrationActive ingredients: fedratinib hydrochloride.
-
Prescription medicine registrationActive ingredients: nivolumab.
-
Prescription medicine registrationActive ingredients: nivolumab.
-
Oct-2024Prescription medicine evaluationActive ingredient: nivolumab.
-
Australian Public Assessment Report (AusPAR)Opdivo (nivolumab), in combination with platinum-doublet chemotherapy, was approved for the neoadjuvant treatment of patients with resectable non-small cell lung cancer.
-
Sep-2024Prescription medicine evaluationActive ingredient: Ipilimumab.
-
Jul-2024Prescription medicine evaluationActive ingredient: nivolumab.
-
Jul-2024Prescription medicine evaluationActive ingredient: Ipilimumab.
-
Cancellation by sponsorRequested by Bristol-Myers Squibb Australia Pty Ltd